Private equity firm One Rock Capital Partners completed the acquisition of Innophos, an international producer of essential ingredients, for $932m. Under the terms of the transaction, the company's stockholders received $32.00 in cash for each share of Innophos common stock they hold. "The closing of this transaction represents an exciting new chapter for Innophos, its employees and customers that furthers its ability to improve quality of life through purpose-built ingredients. As a private company, Innophos is expected to have greater flexibility to drive continued growth in its attractive end markets and strengthen its existing operations. I am thrilled to lead Innophos at this important point in its evolution and look forward to leveraging the substantial resources and expertise of One Rock to deliver unparalleled value to our customers," Richard Hooper, Innophos Chief Executive Officer.